Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
16.40
+0.50 (3.14%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Beta Bionics Revenue
Beta Bionics had revenue of $32.01M in the quarter ending June 30, 2026, with 37.76% growth. This brings the company's revenue in the last twelve months to $119.01M, up 52.54% year-over-year. In the year 2025, Beta Bionics had annual revenue of $100.25M with 53.94% growth.
Revenue (ttm)
$119.01M
Revenue Growth
+52.54%
P/S Ratio
6.20
Revenue / Employee
$281,355
Employees
423
Market Cap
737.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.25M | 35.13M | 53.94% |
| Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
BBNX News
- 11 days ago - Beta Bionics price target raised to $15.50 from $13 at BofA - TheFly
- 11 days ago - Beta Bionics price target lowered to $30.40 from $32 at Ladenburg - TheFly
- 12 days ago - Beta Bionics Earnings Call Transcript: Q2 2026 - Transcripts
- 12 days ago - Beta Bionics Earnings release: Q2 2026 - Filings
- 12 days ago - Beta Bionics Slides: Q2 2026 - Filings
- 12 days ago - Beta Bionics Quarterly report: Q2 2026 - Filings
- 12 days ago - Beta Bionics reports Q2 EPS (53c), consensus (56c) - TheFly
- 12 days ago - Beta Bionics backs FY26 revenue view $131M-$136M, consensus $133.48M - TheFly